EMEA-000982-PIP01-10 - paediatric investigation plan

Furosemide

Key facts

• Active Substance:
  Furosemide
• Therapeutic area:
  Uro-nephrology
• Decision number:
  P/245/2011
• PIP number:
  EMEA-000982-PIP01-10
• Pharmaceutical form(s):
  Orodispersible tablet
• Condition(s) / indication(s):
  Treatment of fluid retention
• Route(s) of administration:
  Oral use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  21/10/2011

Decision

P/245/2011: EMA decision of 21 October 2011 on the agreement of a paediatric investigation plan and on the granting of a waiver for furosemide (EMEA-000982-PIP01-10)

AdoptedReference Number: EMA/826074/2011